Within 8 months of DEN treatment, almost all the Cd24−/− male mice (37/38) developed typical HCC, whereas only 76.5% of WT male mice (26/34) bore tumors (Fig. 1a). The gene discussed is CD24; the disease is hepatocellular carcinoma.